Side Letter: Why Carlyle is cautious of SPACs, French GP breaks its hard-cap
A French tech and healthcare specialist eyes a grand boost in AUM. Plus: An ex-Carlyle director is making waves in China's emerging buyout market and HNWIs are hungry for PE. Here's today's brief, for our valued subscribers only.
